CORD-19:775b90287b44353bee979abb0970a4666022f86d / 76385-76483 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T83927","span":{"begin":0,"end":98},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"After plasmapheresis he continued to receive pulse doses of IVIG for residual neurologic deficits."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T266","span":{"begin":0,"end":98},"obj":"Sentence"}],"text":"After plasmapheresis he continued to receive pulse doses of IVIG for residual neurologic deficits."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T422","span":{"begin":21,"end":23},"obj":"Disease"},{"id":"T27680","span":{"begin":21,"end":23},"obj":"Disease"}],"attributes":[{"id":"A422","pred":"mondo_id","subj":"T422","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"},{"id":"A50154","pred":"mondo_id","subj":"T27680","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"}],"text":"After plasmapheresis he continued to receive pulse doses of IVIG for residual neurologic deficits."}